Search

Author/Creator Wallace, Eli M.

1. Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator. Issue 1 (1st January 2020)

Authors:
Hinklin, Ronald J.; Baer, Brian R.; Boyd, Steven A.; Chicarelli, Mark D.; Condroski, Kevin R.; DeWolf, Walter E.; Fischer, John; Frank, Michele; Hingorani, Gary P.; Lee, Patrice A.; Neitzel, Nickolas A.; Pratt, Scott A.; Singh, Ajay; Sullivan, Francis X.; Turner, Timothy; Voegtli, Walter C.; Wall...
Journal:
Bioorganic & medicinal chemistry
Issue:
Volume 28:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Suppression of HIF2 signalling attenuates the initiation of hypoxia-induced pulmonary hypertension. Issue 6 (12th December 2019)

Authors:
Hu, Cheng-Jun; Poth, Jens M.; Zhang, Hui; Flockton, Amanda; Laux, Aya; Kumar, Sushil; McKeon, Brittany; Mouradian, Gary; Li, Min; Riddle, Suzette; Pugliese, Steven C.; Brown, R. Dale; Wallace, Eli M.; Graham, Brian B.; Frid, Maria G.; Stenmark, Kurt R.
Journal:
European respiratory journal
Issue:
Volume 54:Issue 6(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension. Issue 3 (4th March 2021)

Authors:
Macias, David; Moore, Stephen; Crosby, Alexi; Southwood, Mark; Du, Xinlin; Tan, Huiling; Xie, Shanhai; Vassallo, Arlette; Wood, Alexander J.T.; Wallace, Eli M.; Cowburn, Andrew S.
Journal:
European respiratory journal
Issue:
Volume 57:Issue 3(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗